Autoantibodies against MuSK-Ig1 are biomarkers of disease severity in MuSK MG.
The immune response against MuSK in the majority of patients remains confined to the N-terminus.
Females have a more confined immune response against MuSK than men.
Pyridostigmine responsiveness and side effects do not correlate with specific epitope patterns.